RecruitingNot ApplicableNCT06697106
Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
Sponsor
New Valley University
Enrollment
82 participants
Start Date
Nov 20, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing urethral stricture recurrence after direct visual internal urethrotomy.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria3
- Age ≥ 18 years
- American Society of Anesthesiologists (ASA) score ≤3.
- Urethral stricture length ≤ 1.5 cm
Exclusion Criteria2
- Recurrent urethral stricture ≥ 2 times.
- Pelvic fracture urethral distraction defect (PFUDD).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGNonsteroidal anti-inflammatory drugs
Patients will undergo direct vision internal urethrotomy (DVIU) plus nonsteroidal anti-inflammatory drugs (NSAID) for 3 weeks.
DRUGPlacebo
Patients will undergo direct vision internal urethrotomy (DVIU) plus a placebo for 3 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06697106